Pediatric Clinical Pharmacology Research Program

Children’s National is one of only four sites nationwide that are part of the Eunice Shriver Kennedy National Institute of Child Health and Development funded Research Centers in Pediatric Developmental Pharmacology. Investigators of the Pediatric Clinical Pharmacology Research Program are working to improve the labeling of old and new drugs used to treat neonates, infants, children, and adolescents to guarantee the safe and effective use of medicines in the pediatric population. To accomplish this, our program at Children's National combines basic, translational, and clinical research in the following areas of interest and expertise:

  • Preterm and full-term neonates
  • Children and adolescents with HIV/AIDS
  • Obesity
  • Infectious diseases
  • Prescription opioid use
  • Pediatric pain
  • Duchenne muscular dystrophy
  • Inborn errors of metabolism

The researchers at Children's National are collaborating extensively with other academic centers, the Food and Drug Administration, the National Institutes of Health, and pharmaceutical industry.

In addition Children’s National has become the official pediatric clinical pharmacology training site for the NIGMS funded T32 in clinical pharmacology at Johns Hopkins University allowing additional physicians to receive training in both adult and pediatric clinical pharmacology. 

Faculty members of the Pediatric Clinical Pharmacology Research Program: